RecruitingPhase 3NCT03770923
Effect of Some Drugs on Rheumatoid Arithritis Activity
Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis
Sponsor
Sherief Abd-Elsalam
Enrollment
75 participants
Start Date
Oct 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Effect of Some Drugs on Rheumatoid Arithritis Activity.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is examining how certain medications affect the activity and severity of rheumatoid arthritis — a long-term autoimmune disease where the body's immune system attacks the lining of the joints, causing pain, stiffness, and swelling that can worsen over time. By tracking how patients respond to different drug combinations, researchers hope to find more effective ways to manage the disease and improve patients' quality of life. The study likely involves measuring disease markers in blood or joint fluid alongside monitoring symptoms.
**You may be eligible if...**
- You have been diagnosed with rheumatoid arthritis
- You are willing to participate in the study and attend follow-up appointments
**You may NOT be eligible if...**
- You have liver disease (such as cirrhosis or hepatitis)
- You have kidney (renal) disease that affects your ability to process medications safely
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGRupatadine
Rupatadine 10 mg daily
DRUGMontelukast
Montelukast 10 mg daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03770923
Related Trials
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
NCT076203926 locations
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT0691680637 locations
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
NCT077129391 location
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
NCT071805371 location
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
NCT071719839 locations